Circadiance launched the revolutionary SleepWeaver Advance All-Cloth Nasal CPAP mask at a trade show in Las Vegas last month.
More than 3,000 home care professionals attended the conference where the SleepWeaver Advance nasal CPAP mask received favorable responses from many home care business owners, managers, and respiratory therapists who took time to check out one of the newest masks to the market.
ResMed launched its latest heated humidifier, the H4i, which is the latest technology in heated humidification, according to the company. The humidifier integrates with the S8 Series II CPAP and bi-level devices.
Using the latest technology in airflow dynamics and heating technology helps the H4i heated humidifier delivers the most humidity output of any integrated device with pressure relief.
John L. Miclot, CEO of Philips Home Healthcare Solutions, announced during the Medtrade Keynote Panel discussion last week that he had resigned from Respironics/Philips, effective in two weeks.
Miclot will head up Clearwater, Fla-based CCS Medical, a nationwide provider of various home care staples such as insulin pumps, incontinence products, and respiratory equipment.
ResMed Inc. announced revenue and income results for the fiscal quarter which ended on June 30, 2008. Revenue for the quarter was a record $235.2 million, a 23 percent increase over the fiscal quarter which ended one year ago, on June 30, 2007.
Income from operations and net income for the current quarter were $37.0 million and $29.6 million, respectively. Diluted earnings per share for the quarter ended June 30, 2008 was $0.38. For the quarter ended June 30, 2008, an additional expense of $3.1 million has been recognized as a charge to cost of sales in relation to the voluntary recall announced in April 2007 related to an earlier series of S8 flow generators.
The more than 12 million estimated Americans suffering from sleep apnea don’t have to sacrifice convenience for a good night’s sleep anymore thanks to the increasing abundance of highly efficient and portable electromechanical devices commonly used to treat the disorder.
According to a report from Kalorama Information, Contract Manufacturing Opportunities in High-Growth Medical Devices (Catheters, Pacemakers, LVADs, Hip and Knee Implants, Air Pathways, Syringes), xPAP devices have become the standard and most effective treatment available.
Respironics announced the addition of its first full-face gel mask, the ComfortGel Full, which is part of the company’s Comfort Series line of masks.
With an all-new design and popular components, the ComfortGel Full mask brings the natural comfort and seal benefits of Respironics’ gel technology to full-face mask wearers, while offering the convenience and practicality of a replaceable cushion design to providers.
Vanda, Pharmaceuticals, Proof-of-Concept, Phase II, clinical testing, VSF-173, excessive sleepiness, maintenance of wakefulness tests, MWT, modafinil, Provigil, Nuvigil, narcolepsy, polysomnography, PSG, Mihael Polymeropoulos, shift work sleep disorder, neuro-degenerative disorders, sleep disorders, sleepiness, excessive sleepiness, problem sleepiness.
Respironics, Inc. has announced it’s entered into a merger agreement which will allow Royal Philips Electronics (Philips) to acquire all of the outstanding shares of Respironics for USD 66.00 in cash per share, or a total purchase price of approximately USD 5.1 billion. The offer price represents a premium of approximately 31 percent over Respironics’ average closing share price for a period of 30 trading days ending at market closing on December 20, 2007.
Respironics, Inc. announced it has acquired all outstanding shares of Apollo Light Systems, Inc., a 20-year-old, privately-held company and a leading manufacturer of light therapy systems for melatonin suppression and circadian rhythm sleep disorders.
This is a 2D-barcode containing the address of our mobile site.If your mobile has a barcode reader, simply snap this bar code with the camera and launch the site.
Many companies provide barcode readers that you can install on your mobile, and all of the following are compatible with this format:
As of May 2, 2009 at 9:47 p.m. (-0500) (ET), the U.S. population
was 306,340,710. Sleep researchers estimate approximately seven percent
of the population suffers from obstructive sleep apnea. Using that
estimate, there are potentially 21,443,850 apneics in the U.S.
~~ Apnea around the world ~~
As of May 2, 2009 at 9:47 p.m. (-0500) (ET), the world population
was 6,777,286,604. Sleep researchers estimate approximately seven percent
of the population suffers from obstructive sleep apnea. Using that
estimate, there are potentially 474,410,062 apneics in the world.
